219 words 14 Text: 5616 words 15 16
vaccines or antiviral drugs that offer the advantages of stability and low immunogenicity.
Introduction
HK24 and HK44, as well as positive IgGs purified from pig #3748, were recognized 139 efficiently by epitope-76, while HK24 and HK44 did not bind to the unrelated epitope-75 140 which is a linear epitope on the E2 protein of CSFV. Meanwhile, the positive IgGs interacted 141 efficiently with both epitope-76 and epitope-75. 142 In summary, these data demonstrated that the mAbs HK24 and HK44 can be specifically 143 recognized by epitope-76 with a high affinity.
145
The mAbs HK24 and HK44 exhibit high specificity and sensitivity to the CSFV E2 146 protein 147 The reactivity between the mAbs and the CSFV E2 protein was deciphered via Western 148 blotting. The results showed that the 55-kDa E2 protein band from lysates of CSFV-infected 149 cells was clearly detected by the mAbs HK24 and HK44 with high specificity, unlike the 150 lysates of uninfected cells ( Fig. 3A and 3B) . 151 To further verify the reactivity of the mAbs HK24 and HK44 with the CSFV E2 protein, 152 recombinant E2 protein was subsequently produced and used to detect antibody affinity via 153 Western blotting. As expected, the mAbs HK24 and HK44 reacted with recombinant E2 with 154 high specificity ( Fig. 3C) . Indirect ELISA also showed that the mAbs HK24 and HK44 155 exhibited excellent affinity for the recombinant E2 protein, and binding occurred in a 156 dose-dependent manner, whereas negative IgGs (isolated from CSFV-negative swine serum 157 by protein A) did not show significant reactivity (Fig. 3D) . Together, these results 158 demonstrated that the mAbs HK24 and HK44 possess specific reactivity with either CSFV E2 159 protein in cells or purified recombinant E2 protein. 160 Additionally, to investigate whether the mAbs HK24 and HK44 could be applied for 161 CSFV detection, these antibodies were used to detect CSFV in PK-15 cells via an 162 immunofluorescence assay. As shown in Fig. 3E , the mAbs HK24 and HK44 showed strong 163 fluorescence at 30 nM, as observed for CSFV-positive serum, unlike CSFV-negative serum.
164
This result suggested that both mAbs isolated in the present study could be used to detect 165 CSFV. Hence, our results suggested that the mAbs HK24 and HK44 exhibited high sensitivity 166 towards E2 of CSFV and can be used for the serological detection of CSFV infection or for 167 research purposes. 
Evaluation of the binding affinity of mAbs HK44 and HK24 to E2 protein by SPR

170
SPR is a powerful technique that provides affinity and kinetic information for 171 protein-protein interactions (24, 25) . Thus, SPR was used to assess the ability of the mAbs 172 HK44 and HK24 to bind the recombinant protein E2. For this purpose, the mAbs HK44 and 173 HK24 were immobilized on CM5 sensor chips with a general 1:1 interaction; the results are 174 shown in Fig. 4 . As shown in Fig. 4A and 4B Identification of the binding of the mAbs HK24 and HK44 to a conserved epitope on the 187 CSFV E2 protein based on a 3D structural model 188 To obtain detailed structural information on E2-mAbs interactions, protein-protein 189 docking was performed. Before docking, the best protein modelling result was selected based 190 on the probability density function (PDF) total energy and discrete optimized protein energy 191 (DOPE). The PDF total energy and DOPE of HK24, HK44 and the E2 protein were 192 2296.5857, -45243.882812; 2390.8101, -46726.902344; and 1949.7089, -28135.984375, 193 respectively. Furthermore, there were fewer irrational amino acid residues in the 194 Ramachandran Plot, suggesting that the models we built may exist. Thus, protein-protein to CDR H2 in the HK44-E2 complex ( Fig. 5C and 5D ). In addition, the mAb HK44 also 201 directly bind to Thr88 and Pro90 (a linear epitope on E2 protein spanning Leu84-Pro90 202 residues that has been reported) (26, 27) by means of three residues (Val111A, Ser111B and Detailed interactions between antigen and antibodies are shown in the Table 2 and 3. 208 To further confirm the interaction between mAb HK44 or HK24 and epitope-76, Virtual 209 Alanine Mutation Scanning (VAMS) was employed to calculate mutation energy of 210 individual amino acid residues changes using Discovery Studio 2017. In the case of E2-HK44 211 complex, when the residues of epitope-76 of E2 protein were individually mutated to alanine, 212 seven residues on epitope-76, namely, Val144, Ser145, Pro146, Thr147, Arg150, Glu152, 213 Val154 generated the mutation energy higher than 0.5 kcal/mol, indicating an unstable protein 214 complex (Fig. 5E ). The mutations of epitope-76 in the E2-HK24 complex procedure also 215 destabilize the protein complex (Fig. 5F) . When we mutate all of the epitopes to alanine, the 216 mutation energy is 3.63 kcal/mol for E2-HK24 protein complex and 7.28 kcal/mol for 217 E2-HK44 protein complex, indicating that the protein complex is an unstable state. In 218 summary, these results suggested that the mAb HK24 or HK44 binds to the E2 protein by the 219 recognition of the epitope-76 (CTAVSPTTLRTEVV).
221
MAbs HK24 and HK44 can significantly neutralize CSFV in vitro 222 We next evaluated the protective efficacy of the mAbs HK24 and K44 against CSFV 223 infection in PK-15 cells. A neutralization test was first performed via indirect 224 immunofluorescence assay (IFA). As shown in Fig. 6A , the mAbs HK24 and HK44 displayed high neutralizing activity against CSFV, as no fluorescence was observed at the concentration 226 of 75 μg/ml, and only weak fluorescence signals were detected at the concentration of 1.1 227 μg/ml, which was same as that observed for CSFV-positive serum. In contrast, strong 228 fluorescence signals were detected in cells treated with CSFV-negative serum, indicating no 229 inhibition of CSFV infection. The range of 50% inhibitory concentrations (IC 50 ) to the 230 non-neutralizing concentration for mAbs HK24 and HK44 is presented in Fig. 6B . These 231 results indicated that the mAbs HK24 and HK44 exhibited neutralizing activity against CSFV, 232 and they can prevent CSFV infections in cells.
233
To further directly detect whether the mAbs HK24 and HK44 block CSFV infection, the 234 copy numbers of CSFV RNA in PK-15 cells were analysed via qRT-PCR with specific 235 primers. The results suggested that treating PK-15 cells with the HK44-CSFV or 236 HK24-CSFV complex at concentrations of 75 μg/ml to 1.1 μg/ml resulted in obviously lower 237 numbers of virus copies in the cells than those observed with negative control treatment; at 238 the same time, the mAb HK44 showed better neutralization activity than the mAb HK24 ( Fig.   239 6C and 6D). 240 In summary, these data indicated that the mAbs HK24 and HK44 significantly 241 neutralized CSFV and played an essential role in preventing CSFV from infecting target 242 cells.
244
Discussion
245
CSF is a disease that threatens the pork industry and has caused tremendous economic 246 losses. As an alternative, development of effective vaccines and therapeutics agents may be a 247 direct and effective approach to minimizing these losses. With the technological advances, 248 mAbs now represent an important class of biotherapeutics, which can be used to treat 249 autoimmune disorders diseases, cancer and viral or bacterial infections (28). Thus, it is 250 necessary to establish a simple, highly efficient, low-cost method to produce anti-CSFV 251 NAbs.
252
For generation of human mAbs, there have been previous reports of approaches 253 involving the sorting of single B cells via FACS using fluorescently-labelled specific 254 membrane immunoglobulins as antigen bait; However, this method may be limited by the 255 number of antigenic baiting reagents (29-31). Here, we describe a method for efficient 256 production of mAbs from immunized swine. We used a fluoresceinated linear neutralizing 257 epitope CTAVSPTTLRTEVVK and FITC-labelled goat anti-pig IgG as bait for flow 258 cytometry to screen B cells from a pig that had been pre-screened for high-level The cells were stored at -80°C until use (38, 39) . Western blotting was performed according to a previously described procedure (45).
352
Briefly, equal amounts of proteins were loaded on a 12% SDS-PAGE gel. Next, the separated 353 proteins were transferred onto nitrocellulose membranes, which were blocked with 5% 354 (wt/vol) non-fat milk in Tris-buffered saline that contained 0.2-0.4% Tween-20 (TBS-T) for 2 355 h at room temperature. The membranes were probed with 4 μg/ml mAb or porcine IgGs 356 (hyperimmune serum). Next, the bound antibody was stained using 2 μg/ml horseradish (Beyotime, China) and the Azure c600 Western blot imaging system. Neutralization assays 442 The neutralization activity of the mAbs HK24 and HK44 against CSFV was tested via an 443 immunofluorescence assay as described previously (54 
